Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01954719
Other study ID # 2012-14-06
Secondary ID
Status Recruiting
Phase N/A
First received September 19, 2013
Last updated October 4, 2013
Start date November 2012
Est. completion date January 2014

Study information

Verified date September 2013
Source Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Contact hediye dagdeviren, md
Phone 5079872463
Email hediyedagdeviren@gmail.com
Is FDA regulated No
Health authority Turkey: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this prospective randomised study was to determine the effect of routine cervical dilatation during elective caesarean section on maternal morbidity


Description:

Participants with indication for elective caesarean section were randomly allocated to two groups. Group A (n = 200) women with intraoperative cervical dilatation; group B (n = 200) women with no intraoperative cervical dilatation.Patients were randomised using computer-generated random numbers in sealed envelopes, to place them in one of the groups: group A (n = 200) women with intraoperative cervical dilatation; group B (n = 200) women with no intraoperative cervical dilatation. The investigator was not blinded to the procedure allocation. The allocated envelope was opened by the clinician just before the surgery. The procedure allocation was recorded in the women's charts.Antibiotic prophylaxis of 1 g of intravenous cefazolin or clindamycin 600 mg was given to each woman when the umbilical cord was clamped. In group 1 patients, the surgeon inserted his or her double-gloved index digit in the cervical canal to dilate it and removed the outer gloves after digital dilatation of the cervix.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date January 2014
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:Patients eligible for inclusion were those who had elective caesarean delivery. They had to be more than 37 weeks gestation.

Exclusion Criteria:use of antibiotics during the last 24 h, pathology that should be treated with antibiotics, pre-existing maternal diseases, chorioamnionitis, fever on admission, need of transfusion before or during the caesarean section,ruptured membranes, emergency caesarean section and preterm caesarean section.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
cervix dilated after surgery
The surgeon inserted his or her double-gloved index digit in the cervical canal to dilate it and removed the outer gloves after digital dilatation of the cervix.
control group
surgeon not dilated cervix after surgery

Locations

Country Name City State
Turkey Bakirkoy Dr Sadi Konuk Training and Research Hospital Istanbul Bakirkoy

Sponsors (1)

Lead Sponsor Collaborator
Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Other After elective cesarean section routine cervical dilatation is necessary? Change in post-partum maternal morbidities when compared with a similar group of women receiving intravenous antibiotics and no cervical dilatation at caesarean delivery. We hypothesised that routine intraoperative cervical dilatation during elective section in women receiving intravenous antibiotics would not significantly reduce post-partum maternal morbidities when compared with a similar group of women receiving intravenous antibiotics and no cervical dilatation at caesarean delivery. 24 h after surgery No
Primary The primary outcome was rate of post-partum endometritis The post-partum care for both groups was identical, and included vital signs every four hours, discontinuation of the Foley catheter and advancement of diet on the first postoperative day. All patients in both groups were observed daily in order to assess the following variables: any sign of wound infection (erythema, swelling, discharge or tenderness), vaginal discharge, uterine consistency and height and peritoneal reaction for peritonitis. Clinical signs of urinary tract infection were checked, and urinalysis was performed. A complete blood count was assessed 24 h after delivery. The patients were discharged on third postoperative day if there was no infection or complication. All patients in both groups were observed daily,blood count was assessed 24 h after delivery and the patients were discharged on third postoperative day if there was no infection or complication No
Secondary Secondary outcomes that were analysed included wound infection, febrile morbidity and infectious morbidity. Febrile morbidity was defined as a persistent fever of at least 38 celsius degree for at least 24 h after surgery and not associated with lower abdominal or pelvic tenderness and no signs of infection elsewhere. Partial or total dehiscence or presence of purulent or serous wound discharge with induration, warmth and tenderness was considered as a wound infection. Endometritis was defined here as body temperature greater than 38.5 celsius degree with concomitant foul-smelling discharge or abnormally tender uterus on bimanual examination. A diagnosis of urinary tract infection was only considered when urinary symptoms associated with significant bacteruria (> 10.000.00 organisms/mL) on culture of midstream specimen of urine were noted. Blood loss was estimated using a drop in haemoglobin concentration within 24 h after the operation. Febrile morbidity, blood loss and wound infection diagnosed at least 24 h after surgery No
See also
  Status Clinical Trial Phase
Completed NCT03052699 - Medium and Long-term Complications of the Patients Having Had a Vaginal Caesarian in Hospital René Dubos N/A
Completed NCT01412073 - Control of Blood Loss During Caesarean Section Phase 3
Completed NCT01851187 - Effect of Perinatal Emotional Management on Maternal Emotion and Delivery Outcomes N/A
Completed NCT01890720 - Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section N/A
Completed NCT02542748 - Comparison of Norepinephrine and Ephedrine on Hypotension After Spinal Anesthesia in Parturients N/A
Enrolling by invitation NCT02694653 - Preoperative Cesarean Section Intravenous Acetaminophen and Postoperative Pain Control Phase 1
Completed NCT01723605 - Insitu Repair Versus Uterine Exeriorization During Cesarean Section Phase 3
Withdrawn NCT01516697 - Non-invasive Cardiac Output Monitoring in Obstetric Patients Phase 4
Completed NCT01741610 - Fluid Coloading and the Incidence of Hypotension Phase 4
Terminated NCT02838017 - Tissue Adhesive vs. Sterile Strips After Cesarean Delivery N/A
Completed NCT02587013 - Comparison of Uterine Repair Methods for Cesarean Delivery N/A
Terminated NCT02036697 - Hemodynamic Effects of Low Dose Spinal Anesthesia for Cesarean Section N/A
Terminated NCT02799667 - Do Single Use Negative Pressure Dressings Reduce Wound Complications in Obese Women After Cesarean Delivery N/A
Completed NCT02459093 - Subcuticular Suture for Cesarean Skin Incision Closure Phase 4
Completed NCT01858467 - Supreme LMA and Endotracheal Intubation Use in Caesarean Section N/A
Completed NCT01891006 - Intervention for Postpartum Infections Following Caesarean Section N/A
Withdrawn NCT02893696 - Extra Sitting Time After Spinal Anesthesia for Cesarean Section and Fetal Well-being N/A
Completed NCT02785094 - Education and Social Media Versus Non-Indicated Caesarean Section Rate in Egypt N/A
Completed NCT02332278 - Early Oral Feeding Versus Traditional Postoperative Care After Cesarean Section. N/A
Completed NCT02493608 - Scalpel vs Diathermy in Repeat Cesarean Delivery N/A